HIV Vaccines: Moving from Trials and Errors to Rational Design
Richard A. Koup, MD
Chief, Immunology Laboratory
Deputy Director, Vaccine Research Center
National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2016. All rights reserved.
Richard Koup is a Senior Investigator, Chief of the Immunology Laboratory, and Deputy Director of the Vaccine Research Center (VRC) within the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland. Dr. Koup has spent most of his career studying the protective role of HIV-specific cellular immunity. His specific research involves the characterization of T and B cell factors that are involved in protective immunity against HIV infection, in order to inform the development of vaccines against HIV. He has published over 270 invited and/or peer-reviewed manuscripts on this and related topics, and has mentored 35 graduate and post-graduate students in his career. He serves as an Editor for PLoS Pathogens and on the editorial boards of several other scientific journals.
At the completion of this educational session, learners will:
- Appreciate the importance of the HIV vaccine effort as part of a comprehensive prevention strategy.
- Know the history and future prospects for developing an HIV vaccine.
- Be aware of the challenges still facing HIV vaccine development.
- Have a better understanding of the immunologic strategies being employed, and the potential pitfalls of each.
This CME activity was approved for
AMA PRA Category 1 Credit™ on March 8, 2016 and will terminate March 7, 2019.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Koup (Presenter) had no relevant financial relationships to disclose. Dr. Koup submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Merck & Co, and ViiV Healthcare.
To obtain CME credit for this PRN program, please visit the
PRN Video Channel at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.
